|
|
 Previous Article | Table of Contents | Next Article 
Decreased Interleukin-15 From Activated Cord Versus Adult Peripheral Blood Mononuclear Cells and the Effect of Interleukin-15 in Upregulating Antitumor Immune Activity and Cytokine Production in Cord Blood
John X. Qian,
Sun min Lee,
Yu Suen,
Eva Knoppel,
Carmella van de Ven, and
Mitchell S. Cairo
From the Division of Hematology/Oncology and Blood and Marrow Transplantation Children's Hospital of Orange County, Orange CA.
Interleukin-15 (IL-15) is an important lymphokine regulating natural killer (NK) activity, T-cell proliferation, and T-cell cytotoxic activities. We hypothesized that the reduced expression and production of IL-15 from cord blood (CB) may contribute to the immaturity of CB immunity and potentially delay immune reconstitution after CB transplantation. We compared the expression and production of IL-15 from activated cord versus adult mononuclear cells (MNCs) and the regulatory mechanisms associated with IL-15 expression in CB MNCs. We have also studied the effect of exogenous IL-15 stimulation on CB and adult peripheral blood (APB) MNCs in terms of NK and lymphokine-activated killer (LAK) activities and cytokine induction. Lipopolysaccharide (LPS)-stimulated CB and APB MNCs were used to determine IL-15 expression and protein production by Northern analysis and Western immunoblot analysis. IL-15 mRNA expression and protein accumulation in CB MNC were 25% ± 2.0% (12 hours, n = 4, P < .05) and 30% ± 2.5% (12 hours, n = 3, P < .05), respectively, when compared with APB MNCs. Nuclear run-on assays showed no differences between CB and APB MNCs during basal levels of transcription and after transcriptional activation. However, the half-life of IL-15 mRNA was approximately twofold lower in activated CB MNCs than in activated APB MNCs (CB: 101 ± 5.8 minutes v APB: 210 ± 8.2 minutes, n = 3, P < .05). Exogenous IL-15 significantly enhanced CB NK and LAK activities up to comparable levels of APB (P < .05). IL-15 also significantly induced interferon- (IFN-) and tumor necrosis factor- (TNF-) protein production (days 1, 3, and 6, P < .05, n = 3) in CB MNCs. IL-15-stimulated LAK cells induced a significant lytic response against two acute lymphoblastic cell lines and two pediatric neuroblastoma cell lines. Both NK and LAK activities were augmented by the combination of IL-12 and IL-15, and the low-dose combination of IL-12 and IL-15 achieved similar levels of in vitro NK and LAK cytotoxicity compared with higher doses of either lymphokine. The present study suggests that IL-15 mRNA and protein expression is decreased in activated CB, secondary, in part, to altered posttranscriptional regulation. The reduced production of IL-15 from CB MNCs in response to stimulation may contribute to the decrease in IFN- and TNF- production and CB cellular immunity. However, exogenous IL-15 enhanced IFN- and TNF- production and NK and LAK cytotoxicities in CB MNCs. The reduced production of IL-15 from activated CB may contribute to the immaturity of CB cellular immunity and delayed immune reconstitution after unrelated CB transplantation. Exogenous IL-15 administration may compensate for the immaturity of CB immunity. The synergistic in vitro effects of low-dose IL-12 and IL-15 also implies the possible use of low doses each of IL-12 and IL-15 for enhancing immune reconstitution and/or possibly as a form of antitumor immunotherapy after CB transplantation.
Blood, Vol. 90 No. 8 (July 15), 1997:
pp. 3106-3117
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
Y.-J. Kim, T. M. Stringfield, Y. Chen, and H. E. Broxmeyer
Modulation of cord blood CD8+ T-cell effector differentiation by TGF-{beta}1 and 4-1BB costimulation
Blood,
January 1, 2005;
105(1):
274 - 281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Jiang, C. Van de Ven, P. Satwani, L. V. Baxi, and M. S. Cairo
Differential Gene Expression Patterns by Oligonucleotide Microarray of Basal versus Lipopolysaccharide-Activated Monocytes from Cord Blood versus Adult Peripheral Blood
J. Immunol.,
May 15, 2004;
172(10):
5870 - 5879.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Canto, J. L. Rodriguez-Sanchez, and S. Vidal
Distinctive response of naive lymphocytes from cord blood to primary activation via TCR
J. Leukoc. Biol.,
December 1, 2003;
74(6):
998 - 1007.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. Giron-Michel, A. Caignard, M. Fogli, D. Brouty-Boye, D. Briard, M. van Dijk, R. Meazza, S. Ferrini, C. Lebousse-Kerdiles, D. Clay, et al.
Differential STAT3, STAT5, and NF-{kappa}B activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules
Blood,
July 1, 2003;
102(1):
109 - 117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-J. Kim, R. R. Brutkiewicz, and H. E. Broxmeyer
Role of 4-1BB (CD137) in the functional activation of cord blood CD28-CD8+ T cells
Blood,
October 16, 2002;
100(9):
3253 - 3260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Varas, E. Jimenez, R. Sacedon, M. Rodriguez-Mahou, E. Maroto, A. G. Zapata, and A. Vicente
Analysis of the Human Neonatal Thymus: Evidence for a Transient Thymic Involution
J. Immunol.,
June 15, 2000;
164(12):
6260 - 6267.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Borrione, S. Peola, S. Mariani, B. Besostri, R. Mallone, F. Malavasi, A. Pileri, and M. Massaia
CD38 Stimulation Lowers the Activation Threshold and Enhances the Alloreactivity of Cord Blood T Cells by Activating the Phosphatidylinositol 3-Kinase Pathway and Inducing CD73 Expression
J. Immunol.,
May 15, 1999;
162(10):
6238 - 6246.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. de La Selle, E. Gluckman, and M. Bruley-Rosset
Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect in Mice Grafted With Peripheral Newborn Blood
Blood,
November 15, 1998;
92(10):
3968 - 3975.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
